Integra LifeSciences to Present at the Oppenheimer 20th Annual Healthcare Conference
PLAINSBORO, N.J., Oct. 28, 2009 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will present at the Oppenheimer 20th Annual Healthcare Conference.
On Wednesday, November 4th, 2009 at 1:35 PM, Gerry Carlozzi, Executive Vice President and Chief Operating Officer of Integra, will present at the Oppenheimer 20th Annual Healthcare Conference to be held at the Waldorf-Astoria in New York City. A webcast of this presentation can be accessed via a link provided on the Investor Relations homepage of Integra's website at www.Integra-LS.com. Additionally, a replay of the event will be archived there.
Integra LifeSciences Holdings Corporation, a world leader in regenerative medicine, is a global medical device company dedicated to improving the quality of life for millions of patients every year. Our products are used primarily in orthopedics, neurosurgery and general surgery. Headquartered in Plainsboro, New Jersey, Integra has research and manufacturing facilities throughout the world. For more information, visit www.Integra-LS.com.
Statements made at the upcoming conferences may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties that could cause actual results to differ from predicted results. Forward-looking factors that may be discussed include, but are not limited to, future financial performance, new product development, governmental approvals, market potential and resulting sales as well as potential therapeutic applications, and additional acquisitions. These risks and uncertainties include market conditions and other factors beyond the Company's control and the economic, competitive, governmental, technological and other factors identified under the heading "Risk Factors" included in item IA of Integra's Annual Report on Form 10-K for the year ended December 31, 2008 and information contained in subsequent filings with the Securities and Exchange Commission could affect actual results. These forward-looking statements are made only as the date thereof, and the Company undertakes no obligation to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise.
IART-G
CONTACT: Integra LifeSciences Holdings Corporation
John B. Henneman, III, Executive Vice President,
Finance and Administration and Chief Financial Officer
(609) 275-0500
jhenneman@Integra-LS.com
Investor Relations:
Angela Steinway
(609) 936-2268
angela.steinway@Integra-LS.com
(C) Copyright 2009 GlobeNewswire, Inc. All rights reserved.